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ABSTRACT
The pandemic spread of human immunodeficiency virus (HIV) has been the greatest challenge to public health 
in modern times. However today, people infected with HIV are living longer due to highly active antiretroviral 
therapy (HAART). This has resulted in age related complications like cardiovascular diseases, causing increased 
morbidity and mortality. The relative contributions of HIV infection versus potential adverse effects of HAART 
to coronary heart disease risk remains unclear. Recent reports implicate both HIV infection per se and HAART 
therapy to cause metabolic derangements which are pro-atherogenic. Here, we report a case of HIV infected 
young patient never exposed to HAART, presenting with accelerated atherosclerosis in aorta, coronary and 
carotid arteries.
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INTRODUCTION
Human immunodeficiency virus (HIV) infected individuals 
have an increased risk of coronary heart disease   
(CHD).[1-3] The cause might be the viral infection itself, 
the use of highly active antiretroviral therapy (HAART) or 
altered immune responses seen in these patients.[2] The risk 
is influenced by traditional factors such as age, smoking, 
diabetes and dyslipidemia as well as non-traditional factors 
like local and systemic inflammation. Clinical presentation 
of CHD in HIV infected patients tends to be different from 
CHD due to traditional risk factors in that they present 
at an age which is almost a decade younger, with a mean 
age of 50 years, compared with non- infected controls.[2] 
Early diagnosis of CHD is of paramount importance in 
the present day scenario where HIV infection has become 
a manageable but not yet curable, chronic condition.
CASE REPORT
A 36 year old man, who met with a road traffic accident, was 
admitted to the hospital with severe head injuries. During 
his stay in the hospital he was diagnosed to be infected with 
HIV. He was a smoker, non alcoholic, non-diabetic and had 
no past history of CHD symptoms or family history of 
CHD. He died on the 8th day of admission and an autopsy 
was conducted. Grossly, the aorta showed extensive 
areas of atherosclerosis [Figure 1]. Coronary [Figure 2] 
and carotid arteries showed atherosclerotic plaques and 
narrowing of the lumen. Microscopy and histopathological 
examination with hematoxylin and eosin staining 
showed well formed atherosclerotic plaques in the aorta   
[Figures 3 and 4], circumferential involvement of all the 
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three coronary vessels [Figures 5 and 6] and carotid arteries 
with large lipid cores, intense inflammation, abundant 
foam cells, speckled calcification, thin cap atheroma and 
lack of normal vessel wall between the atheromas.
DISCUSSION
With advancements in medicine and HAART therapy, 
people with HIV infection are now living longer and an 
understanding of its relationship with development of 
Figure 1: Gross photograph of aorta showing marked large 
atheromas
atherosclerosis is the need of the hour. Whether HIV 
infection per se is an independent CHD risk factor, or it 
is solely due to HAART remains controversial.[4] Clinical 
and epidemiological studies have shown relation between   
HIV infection and increased risk of CHD across large 
cohorts.[1] People with HIV infection have 1.5 to 2 fold 
higher incidence of cardiovascular events reported, 
compared with uninfected individuals.[1-4] When first 
reports of myocardial infarction in young HIV infected 
patients surfaced, the initial focus was primarily on the 
Figure 2: Gross photograph of coronary arteries showing marked 
narrowing with atheroma in the wall
Figure 3: Microphotograph of aorta showing well formed atheromatous 
plaque with lipid core (hematoxylin and eosin stain, 100×)
Figure 4: Microphotograph of aorta showing foamy macrophages 
(arrows) in athermatous plaque (hematoxylin and eosin stain, 400×)
Figure 5: Microphotograph of coronary artery showing well formed 
athermatous plaque with lipid core (arrow heads), cholesterol crystals 
(arrow) and angiogenesis (star) (hematoxylin and eosin stain, 100×)
Figure 6: Microphotograph of coronary artery showing athermatous 
plaque with a thin cap (hematoxylin and eosin stain, 100×)243 Journal of Cardiovascular Disease Research Vol. 2 / No 4
Kalyani, et al.: Accelerated atherosclerosis in a HIV infected patient
dyslipidemic effects of antiretroviral therapy.[5] Only 
recently, the broader appreciation of the complex interplay 
between traditional risk factors for CHD and HIV 
infection has emerged.[5]
The mechanisms by which HIV causes increased 
atherosclerosis and CHD has been the topic of great interest 
to physicians, pathologists and cardiologists. Although exact 
pathogenesis needs to be proved and verified, many possible 
mechanisms have been proposed with significant evidence 
to back them. Traditional risk factors like age, smoking, 
hypertension and diabetes are all strong predictors of 
CHD risk in HIV infected patients. HIV serves as a marker 
for a subgroup of the general population with an altered 
prevalence of traditional risk factors in particular, with the 
rate of smoking in HIV populations being consistently 
high and exceeding that for age-matched controls in 
several studies.[5] A French cohort study reported smoking 
prevalence rate of 56.6% in HIV infected men Vs 32.7% 
in HIV negative men.[3] The prevalence of hyperlipidemia 
in HIV patients is between 28-80% in different studies.[2] 
In the early stages of HIV infection before treatment is 
instituted, the predominant changes in the lipid profile are: 
hypertriglyceridaemia, low high density lipoproteins and 
high LDL (low density lipoprotein) values with predominant 
small, dense LDL particles which are highly atherogenic, 
compared with controls.[1-5] The overall effect of HIV 
infection on the lipid profile is atherogenic.[2,5] The proposed 
mechanisms for the lipid abnormalities include increased 
hepatic lipogenesis, impaired clearance of lipids from the 
blood stream and potential effects on immunologic status.[2]
The effects of HIV on non-traditional risk factors 
like local and systemic inflammation and endothelial 
function have gained importance in recent times. Chronic 
inflammation plays a central role in the development of 
atherosclerosis. Increased vascular inflammation seen 
in HIV infection might be due to direct viral infection 
or due to the associated metabolic defects.[2] Vascular 
inflammation causes endothelial cell activation leading to 
an increased expression of adhesion molecules and also 
causes activation of the monocytes.[1,2] This in turn leads to 
an increased migration of monocytes into the atherogenic 
lesion, maturation into macrophages and conversion 
into lipid rich foam cells.[1] Activated macrophages are 
a major source of cytokines and chemokines that direct 
monocytes into the vascular lesions, creating a positive 
feedback loop.[1,6] More recently, HIV infection has been 
shown to interfere with the cholesterol efflux from the 
macrophages resulting in accumulation of many foam cells, 
subsequent necrosis and apoptosis of these cells leading 
to the formation of the lipid core of the atheroma.[1] HIV 
infection impairs reverse cholesterol transport whereas 
HAART affects mostly forward cholesterol transport 
(increasing cholesterol delivery to cells).[1]
The present case highlights the role of traditional risk 
factors like male sex and smoking in the causation of 
atherosclerosis which seems to be accelerated by the HIV 
infection induced inflammation. Since the patient was never 
exposed to HAART nor did he have a positive family history 
of CHD, the accelerated atherosclerosis was most probably 
caused by smoking and HIV infection. Histopathological 
examination showed circumferential atheromas with 
complication in all the three coronary vessels, carotid arteries 
and aorta. Lesions with large lipid core and thin cap carry 
a higher risk of rupture and thrombosis.
CONCLUSION
HIV related cardiovascular disease is an under-recognized 
cause for symptomatic illness.[7] A high degree of suspicion 
and early screening may allow appropriate intervention and 
improved quality of life in those affected. Observations in 
the present case highlight the fact that traditional factors 
such as smoking need to be controlled for reducing CHD. 
These patients should be prescribed statins and platelet 
anti-aggregants along with antiretroviral regimens.[8] 
Strategies to decrease cardiovascular risk in HIV infected 
patients will be important in the public health perspective.
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